GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Ani Pharmaceuticals Inc. (ANIP) [hlAlert]

Rating:
Buy ANIP
up 8.25 %

Ani Pharmaceuticals Inc. (ANIP) upgraded to Buy with price target $60 by ROTH Capital

Posted on: Monday,  Sep 28, 2015  8:25 AM ET by Roth Capital

Roth Capital rated Buy Ani Pharmaceuticals Inc. (NASDAQ: ANIP) on 09/28/2015, when the stock price was $44.31. Since
then, Ani Pharmaceuticals Inc. has gained 8.26% as of 01/05/2016's recent price of $47.97.
If you would have followed this Roth Capital's recommendation on ANIP, you would have gained 8.25% of your investment in 99 days.

Biosante Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing products for female sexual health, menopause, contraception and male hypogonadism. The Company primary products include gel formulations of testosterone and estradiol. It is also engaged in the development of its calcium phosphate nanotechnology (CaP), primarily for aesthetic medicine, vaccines and drug delivery. The Company?s principal products include LibiGel, Bio-T-Gel and Pill-Plus. The Company?s CaP products in development include BioLook, BioVant, BioOral and BioAir. In October 2009, BioSante Pharmaceuticals, Inc. and Cell Genesys, Inc. announced the completion of the merger of Cell Genesys, Inc. with and into BioSante Pharmaceuticals, Inc., with BioSante Pharmaceuticals, Inc. as the surviving company. Pursuant to the merger, BioSante Pharmaceuticals, Inc. has acquired all of the outstanding shares of Cell Genesys, Inc.

ROTH researches emerging growth equities in the media, technology, telecommunications, healthcare, consumer, energy and industrial sectors. The research is focused on companies with market capitalization of between $100 million - $1 billion. Our coverage universe includes approximately 180 small cap growth companies around the globe including several companies from China. With an average market cap of approximately $500 million, our objective is to identify rapidly growing companies with significant long term growth prospects.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/28/2015 8:25 AM Buy
None
44.31 60.00
as of 8/27/2015
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/4/2015 3:25 PM Hold
None
60.85 67.00
5/18/2015 11:25 AM Hold
None
51.94 60.00
4/10/2015 8:25 AM Hold
None
67.69 78.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy